Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of the Korean Neurological Association ; : 372-375, 2019.
Artigo em Coreano | WPRIM | ID: wpr-766822

RESUMO

Cefepime is a fourth-generation cephalosporin, developed in 1994, and is well known for its adverse effects. In 2002, the Food and Drug Administration adjusted the labeling to account for increased risk of seizures, encephalopathy and myoclonus, especially in the setting of renal impairment. Here we present a case of an 86-year-old female, undergoing Cefepime treatment, with encephalopathy mimicking acute stroke.


Assuntos
Idoso de 80 Anos ou mais , Feminino , Humanos , Encefalopatias , Mioclonia , Convulsões , Acidente Vascular Cerebral , United States Food and Drug Administration
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA